The present study aimed to investigate the impact of p53 status on the response to high LET RT in cancer cells and evaluate the potential of a p53 reactivation strategy to enhance the efficacy when diffusing alpha emitting RT is applied to treated tumors with mutation in TP53. This evidence concerns the gene TP53 and cancer.